Heart repair drug trial halted before first patient
Disease control
Terminated
This study aimed to test whether an experimental drug called CDR132L could help improve the structure and function of the heart in people with a specific type of heart failure where the heart pumps normally but is stiff and thickened. The trial planned to enroll about 130 patient…
Phase: PHASE2 • Sponsor: Cardior Pharmaceuticals GmbH • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC